CRiL

About CRiL

Cambridge Respiratory Innovations, founded in 2013, aims to revolutionize respiratory care with its cutting-edge technology. The company has developed the world's first ultra high sensitivity handheld capnometer, which is fully connected and provides real-time respiratory data. This device, protected by patents, is designed to be simple to use with minimal training, making it suitable for both clinical and home settings. The core technology involves advanced CO2 sensing that collects extensive data from normal breathing, offering new insights into lung function. The company also integrates proprietary data analytics software and artificial intelligence to deliver actionable insights at the point of care. Cambridge Respiratory Innovations serves healthcare providers, clinical researchers, and patients, operating primarily in the medical technology market. The business model includes selling the capnometer devices and offering data analytics services. Revenue is generated through device sales, software subscriptions, and partnerships in clinical trials and research projects.